Your search for bevacizumab returned 16 results

Both linked to improvements in visual acuity; only triamcinolone tied to sustained improvement in CMT

No evidence of infection, inflammation when bevacizumab is stored at 4 Celsius for a week

Findings show benefits compared with FOLFIRI for patients with untreated metastatic disease.

The systemic safety of bevacizumab appears to be similar to that of ranibizumab as intravitreal therapy for neovascular age-related macular degeneration (AMD).

Adjuvant bevacizumab increases overall survival in cervical cancer and improves progression-free survival in glioblastoma.

For patients with diabetic macular edema (DME), visual acuity (VA) improves over two years with treatment with different anti-vascular endothelial growth factor (VEGF) agents, according to a study published online in Ophthalmology.

Dose-dense weekly paclitaxel does not improve progression-free survival in ovarian cancer, according to a study published in the New England Journal of Medicine.

A case of central retinal vein occlusion (CRVO) two days after phendimetrazine use has been documented and published online in JAMA Ophthalmology.

An experimental vaccine and a drug already on the market each may help slow down advanced ovarian cancer, two new studies suggest.

Fewer U.S. colorectal cancer patients who are diagnosed in the final stages of their disease are having what can often be unnecessary surgery to have the primary tumor removed, researchers report.